Chemoinformaics analysis of guanidinosuccinic-acid
| Molecular Weight | 370.401 | nRot | 6 |
| Heavy Atom Molecular Weight | 348.225 | nRig | 22 |
| Exact Molecular Weight | 370.142 | nRing | 4 |
| Solubility: LogS | -5.214 | nHRing | 2 |
| Solubility: LogP | 3.319 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 54.5514 |
| nHD | 0 | BPOL | 31.6186 |
| QED | 0.729 |
| Synth | 3.1 |
| Natural Product Likeliness | 1.076 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.998 |
| Pgp-sub | 0 |
| HIA | 0.001 |
| CACO-2 | -4.842 |
| MDCK | 0.0000268 |
| BBB | 0.275 |
| PPB | 0.969105 |
| VDSS | 1.158 |
| FU | 0.0299854 |
| CYP1A2-inh | 0.956 |
| CYP1A2-sub | 0.894 |
| CYP2c19-inh | 0.963 |
| CYP2c19-sub | 0.843 |
| CYP2c9-inh | 0.901 |
| CYP2c9-sub | 0.885 |
| CYP2d6-inh | 0.958 |
| CYP2d6-sub | 0.936 |
| CYP3a4-inh | 0.98 |
| CYP3a4-sub | 0.886 |
| CL | 14.804 |
| T12 | 0.401 |
| hERG | 0.3 |
| Ames | 0.162 |
| ROA | 0.011 |
| SkinSen | 0.793 |
| Carcinogencity | 0.811 |
| EI | 0.086 |
| Respiratory | 0.246 |
| NR-Aromatase | 0.394 |
| Antiviral | No |
| Prediction | 0.719724 |